EUVIMEDEUVIMED entdecken
Crossref

Primary Aldosteronism and Drug Resistant Hypertension: A “Chicken-Egg” Story

L Lenzini, G Pintus, G Rossitto, T M Seccia, G P Rossi

Experimental and Clinical Endocrinology & Diabetes · 01.08.2023 · 131 (07/08) · 409-417

DOI: 10.1055/a-2073-3202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.08.2023. Verfasst von L Lenzini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Internal & Emergency Medicine Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy. Hauptthemen laut MEDLINE: Hyperaldosteronism, Hypertension. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 96 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-resistant arterial hypertension (RH) is a major risk factor for cardiovascular disease, often due to overlooked underlying causes. Identification of such causes poses significant clinical challenges. In this setting, primary aldosteronism (PA) is a frequent cause of RH and its prevalence in RH patients is likely higher than 20%. The pathophysiological link between PA and the development and maintenance of RH involves target organ damage and the cellular and extracellular effects of aldosterone excess that promote pro-inflammatory and pro-fibrotic changes in the kidney and vasculature. The feasibility of adrenal vein sampling in PA patients with RH, and the clinical benefit achieved by adrenalectomy, further emphasize the need to implement systematic screening for this common form of secondary hypertension in the management of a high-risk population as RH patients. We herein review the current knowledge of the factors that contribute to the RH phenotype with a focus on PA and discuss the issues regarding the screening for PA in this setting and the therapeutic approaches (surgical and medical) aimed at resolving RH caused by PA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperaldosteronismHypertensionHumansAldosteroneAdrenalectomyRisk Factors

Substanzen

Aldosterone

Autor:innen und Institutionen

  • Internal & Emergency Medicine Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy.

Zitieren

APA

Lenzini, L., Pintus, G., Rossitto, G., Seccia, T. M., & Rossi, G. P. (2023). Primary Aldosteronism and Drug Resistant Hypertension: A “Chicken-Egg” Story. Experimental and Clinical Endocrinology & Diabetes, 131(07/08), 409-417. https://doi.org/10.1055/a-2073-3202

Vancouver

Lenzini L, Pintus G, Rossitto G, Seccia TM, Rossi GP. Primary Aldosteronism and Drug Resistant Hypertension: A “Chicken-Egg” Story. Experimental and Clinical Endocrinology & Diabetes. 2023;131(07/08):409-417. doi:10.1055/a-2073-3202

BibTeX
@article{Lenzini2023,
  author = {Lenzini, L and Pintus, G and Rossitto, G and Seccia, T M and Rossi, G P},
  title = {Primary Aldosteronism and Drug Resistant Hypertension: A “Chicken-Egg” Story},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2023},
  volume = {131},
  number = {07/08},
  pages = {409--417},
  doi = {10.1055/a-2073-3202}
}
Kostenlos starten →